Icon Writers
Icon Cancer Centre has partnered with Macquarie University Health (MUH) to establish the next phase of precision radiotherapy in the country, delivering a comprehensive stereotactic Centre of Excellence.
The Icon Cancer Centre and Macquarie University Health service in Sydney will be the only centre in Australia to offer all three leading precision-radiation technologies in one location: Gamma Knife, CyberKnife, and a linear accelerator (linac).
These technologies are at the forefront of precision cancer care, providing highly targeted, less invasive treatment options - improving accuracy, minimising side effects, and reducing the burden of time and travel for patients and their families.
“We’re proud to partner with Macquarie University Health to deliver this next phase of precision radiotherapy, setting a new benchmark for integrated cancer care in Australia,” said Icon Cancer Centre Australia and New Zealand CEO, Paul Fenton.
“Bringing such advanced technologies together on one campus enables highly personalised, targeted treatment while also building on our shared commitment to clinical excellence, research and innovation.
“Most importantly, it ensures patients in New South Wales can access the absolute latest in cancer care in one integrated setting, close to home.”
Around 50% of all patients diagnosed with cancer require radiation oncology services.
The new Icon Cancer Centre and Macquarie University Health service is scheduled to begin in May 2026, ensuring continuity of care as the service transitions, with the new technologies available to patients by the end of the year.
This additional centre will see the number of Icon Cancer Centre services in New South Wales grow to seven, with existing cancer care centres in Wahroonga, Concord, Revesby, Norwest, Gosford and Maitland.